A newly identified protein interaction that affects cell cycle regulation may be an attractive target for cancer therapy.

To study the dynamics of structural proteins in the heart, Vanderbilt investigators generated a cellular tool they expect will be useful for screening drugs that affect heart muscle contraction.

Vanderbilt neurologists have identified a protein modification that could be targeted to reduce neuronal excitability in epilepsy.

A computational method that uses hospital billing codes and electronic health records can identify genetic disease cases before clinical teams do.

Obesity and two post-operative complications linked with it have associated genetic variants in common, suggesting that obesity may be the culprit.

Vanderbilt researchers have uncovered another piece in the puzzle of how cells divide — a process that goes awry in cancer cells.

Structural details of a protein that is essential to normal brain function could improve treatments for epilepsy and other seizure disorders.